UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
CEO of insulin pump maker embroiled in ‘gapjil’ controversy
Choi Soo-bong, a professor at Konkuk University’s Graduate School of Medici...
by Lee Hye-seon
|
2018-12-28 14:10
라인
Withus Pharmaceutical punished for skipping quantitative test
The government ordered Withus Pharmaceutical to suspend manufacturing of Re...
by Lee Hye-seon
|
2018-12-21 15:37
라인
Astellas Korea rebuked for arbitrarily modifying trials
Astellas Korea received administrative punishment for changing details of t...
by Lee Hye-seon
|
2018-12-20 11:05
라인
Drugmaker booked for bribing doctors with propofol discounts
The police caught a pharmaceutical firm bribing physicians by selling anest...
by Lee Hye-seon
|
2018-12-19 14:12
라인
Handok to test new insomnia drug in phase-3 study
Handok said it would conduct a global phase-3 clinical trial to test Nemore...
by Lee Hye-seon
|
2018-12-19 11:44
라인
Kyung Nam Pharm shareholders lambast delisting decision
The nation’s stock market operator said on Friday it decided to delist Kyun...
by Lee Hye-seon
|
2018-12-17 11:57
라인
Robotic surgery experts gather in Seoul for conference
Experts in robotic surgery around the world have gathered at the Severance ...
by Lee Hye-seon
|
2018-12-14 15:16
라인
Handok to test diabetes-yslipidemia combo
Handok said it has started developing a combination drug, mixing type-2 dia...
by Lee Hye-seon
|
2018-12-12 16:18
라인
Machine learning finds biomarker for rare Castleman Disease
Medidata, a cloud-based solution provider for clinical research, said it ha...
by Lee Hye-seon
|
2018-12-11 17:11
라인
Servier Korea fails to fix packaging error
Servier Korea received a warning from the Ministry of Food and Drug Safety ...
by Lee Hye-seon
|
2018-12-11 10:49
라인
AbbVie to test rheumatoid arthritis drug’s efficacy in ulcerative colitis
AbbVie said it would conduct a phase-3 clinical trial on upadacitinib, a tr...
by Lee Hye-seon
|
2018-12-07 15:29
라인
Side effects of breast fillers warned
After Japanese women reported side effects of breast enlargement surgeries ...
by Lee Hye-seon
|
2018-12-06 15:58
라인
AstraZeneca’s immunotherapy Imfinzi arrives in Korea
AstraZeneca’s immunotherapy Imfinzi (ingredient: durvalumab) won domestic s...
by Lee Hye-seon
|
2018-12-05 17:12
라인
Pfizer’s rheumatoid arthritis drug adds indication for ulcerative colitis
Pfizer Korea said it won approval for Xeljanz Tab. 10mg (tofacitinib citrat...
by Lee Hye-seon
|
2018-12-04 11:17
라인
Will Lilly’s breast cancer drug work on prostate cancer?
Lilly said it would test its investigational breast cancer treatment Abemac...
by Lee Hye-seon
|
2018-11-29 15:02
라인
Yuhan develops 3-drug combo for hypertension, dyslipidemia
Yuhan Corp. said it has developed a combination drug mixed Duowell (telmisa...
by Lee Hye-seon
|
2018-11-28 15:36
라인
Philips enters mobile ultrasound biz, challenging Healcerion
Philips Korea has entered the wireless ultrasound device market led by Heal...
by Lee Hye-seon
|
2018-11-28 14:20
라인
13 firms win nod for bioequivalence test on generics for Parkinson’s
Domestic pharmaceutical companies have been competing to develop generic co...
by Lee Hye-seon
|
2018-11-27 10:44
라인
China eases customs for Korean chemical drugs
China will carry out customs inspection on Korean chemical medicines only o...
by Lee Hye-seon
|
2018-11-19 15:46
라인
Government to overhaul generic drug approval system
The Ministry of Food and Drug Safety plans to fix up problems caused by the...
by Lee Hye-seon
|
2018-11-19 11:59
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top